This bill amends existing telehealth and telemedicine regulations in New Jersey, specifically regarding the prescription of certain Schedule II controlled substances for adults diagnosed with attention-deficit/hyperactivity disorder (ADHD). Under current law, an initial in-person examination is required before prescribing these substances, with follow-up in-person visits mandated every three months. The new provisions allow for a more flexible approach for adult patients, permitting follow-up consultations to occur via telemedicine or telehealth every six months after the initial in-person examination, while still maintaining the requirement for the initial visit.

Additionally, the bill clarifies that the existing regulations for minor patients remain unchanged, meaning that minors still require an initial in-person examination and follow-up visits every three months. The legislation aims to streamline the process for adult patients while ensuring that the necessary standards of care are upheld. The bill takes effect immediately upon passage.

Statutes affected:
Introduced: 45:1-62